Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 123.52B | 123.52B | 126.44B | 120.65B | 118.05B | 114.25B |
Gross Profit | 33.37B | 33.37B | 31.74B | 31.91B | 32.41B | 64.79B |
EBITDA | 13.74B | 13.74B | 12.82B | 10.06B | 13.27B | 14.45B |
Net Income | 7.57B | 7.57B | 6.72B | 4.08B | 6.22B | 6.65B |
Balance Sheet | ||||||
Total Assets | 137.09B | 137.09B | 140.23B | 128.98B | 125.41B | 120.04B |
Cash, Cash Equivalents and Short-Term Investments | 19.47B | 19.47B | 22.08B | 20.79B | 25.25B | 26.59B |
Total Debt | 20.30B | 20.30B | 28.09B | 31.72B | 33.69B | 34.58B |
Total Liabilities | 56.82B | 56.82B | 67.54B | 69.08B | 70.27B | 72.36B |
Stockholders Equity | 80.27B | 80.27B | 72.69B | 62.92B | 59.90B | 55.14B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.62B | 2.54B | 2.87B | 4.42B | 405.00M |
Operating Cash Flow | 0.00 | 8.50B | 4.62B | 8.17B | 11.31B | 12.16B |
Investing Cash Flow | 0.00 | -2.30B | 843.00M | -5.74B | -5.74B | -11.21B |
Financing Cash Flow | 0.00 | -8.76B | -4.42B | -2.90B | -2.90B | 3.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥88.89B | 11.74 | 1.61% | -0.76% | -8.38% | ||
71 Outperform | ¥28.66B | 11.76 | 1.64% | 1.31% | 10549.54% | ||
70 Outperform | ¥67.60B | 10.78 | 2.87% | -4.47% | -7.10% | ||
70 Outperform | ¥262.88B | 20.53 | 1.93% | 11.08% | -46.09% | ||
67 Neutral | ¥23.93B | 24.59 | 1.75% | 3.96% | -42.78% | ||
63 Neutral | $20.49B | 14.78 | -2.88% | 3.11% | 1.86% | -5.76% |